OxyContin Heir Buys Bel Air Mansion For $22.5 Million IN CASH

By on March 15, 2018 in ArticlesBillionaire News

Purdue Pharma is the maker of the opioid painkiller OxyContin. That controversial drug is at the center of the American opioid crisis. From 2016 to 2017 opioid overdoses have increased by 30%. More than 300,000 Americans have lost their life due to an opioid addiction. However, business is booming for the makers of OxyContin. One of the heirs to the OxyContin fortune just bought a Bel Air mansion for $22.5 million IN CASH.

David Sackler, the son and nephew of the owners of Purdue Pharma just closed escrow on a 10,000 square foot 1980s estate with a long, private driveway. The home is set on four acres, has a two story atrium, spiral staircase, amazing views, tennis court, pool, media room, game room, and gym. The master suite occupies almost the entire second floor.

Sackler's grandfather is one of the three brothers who founded and ran Purdue Pharma. He is in his late 30s. Purdue Pharma is still 100% owned by the Sackler family. None of the Sacklers have personally been charged in the many lawsuits against Purdue Pharma. An estimated 20 Sackler heirs share the $14 billion fortune. David runs the family's investment firm and is the only member of the third generation of Sacklers to sit on Purdue Pharma's board of directors.

Sackler's real estate agent was Josh Altman of "Million Dollar Listing" fame.

Articles Written by Amy Lamare
Amy Lamare is a Los Angeles based writer covering business, technology, entertainment, philanthropy, and pop culture. She spent 8 1/2 years covering the entertainment industry for www.hsx.com. She has written for Los Angeles Magazine, Your Tango, Thinknum Media, and various airline magazines. Follow her on Facebook. Amy's favorite self-made billionaire is Sara Blakely.
Did we make a mistake?
Submit a correction suggestion and help us fix it!
Submit a Correction
Discussion